FOR IMMEDIATE RELEASE:
Branford, CT – December 21, 2006 – CAS Medical Systems, Inc. (NASDAQ: CASM), a medical device company focused on innovative non-invasive vital signs monitoring, announced that NASDAQ has approved the Company’s application to move its exchange listing from the NASDAQ Capital Market to the NASDAQ Global Market. Effective tomorrow, December 22, 2006, the Company’s shares will begin trading on the Global Market; the Company’s trading symbol will remain CASM.
Louis P. Scheps, President and CEO of CASMED, stated, “Being listed on the NASDAQ Global Market is yet another milestone for the Company this year. Our progression from the Capital Market to the Global Market is a testament to our continued positive growth. This move is significant for both the Company and its shareholders and will provide us with the opportunity to improve our visibility with institutional investors and enhance our value.”
About NASDAQ Global Market
The NASDAQ Global Market consists of over 2300 companies that have met and continue to meet stringent financial and liquidity requirements and have agreed to meet specific corporate governance standards. Formerly called The NASDAQ National Market, this market was renamed in 2006 to reflect the global leadership and international reach of this market and the companies whose securities are listed here.
About CAS Medical Systems, Inc. (CASMED™)
Founded in 1984, CAS Medical Systems, Inc. is dedicated to the design and manufacture of innovative technologies and products vital to patient care in the most challenging clinical environments. Its current product lines include blood pressure measurement technology, vital signs monitoring equipment, blood pressure cuffs, apnea monitoring equipment and products for neonatal intensive care. With a reputation for the highest quality products available in the markets it serves, CASMED products are used by clinicians worldwide.
For more information contact:
Statements included in this press release, which are not historical in nature, are forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Statements relating to the future performance of the Company are subject to many factors including, but not limited to, the customer acceptance of the products in the market, the introduction of competitive products and product development, commercialization and technological difficulties, and other risks detailed in the Company’s most recent Form 10-KSB and other Securities and Exchange Commission filings.
Such statements are based upon the current beliefs and expectations of the Company’s management and are subject to significant risks and uncertainties. Actual results may differ from those set forth in the forward-looking statements. When used in this press release the terms "anticipate", "believe", "estimate", "expect", "may", "objective", "plan", "possible", "potential", "project", "will" and similar expressions identify forward-looking statements. The forward-looking statements contained in this press release are made as of the date hereof, and we do not undertake any obligation to update any forward-looking statements, whether as a result of future events, new information or otherwise.